Susana Rovira Llopis-rekin lankidetzan egindako argitalpenak (20)

2019

  1. Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?

    Antioxidants and Redox Signaling, Vol. 30, Núm. 2, pp. 232-240

  2. The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  3. The mitochondria-targeted antioxidant MitoQ modulates mitochondrial function and endoplasmic reticulum stress in pancreatic β cells exposed to hyperglycaemia

    Cellular Physiology and Biochemistry, Vol. 52, Núm. 2, pp. 186-197

2018

  1. Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells?

    Antioxidants and Redox Signaling, Vol. 28, Núm. 17, pp. 1562-1569

  2. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation

    Cellular Physiology and Biochemistry, Vol. 50, Núm. 3, pp. 1015-1028

  3. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 17, pp. 1439-1445

  2. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients

    Free Radical Biology and Medicine, Vol. 108, pp. 155-162

  3. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications

    Redox Biology, Vol. 11, pp. 637-645

  4. Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1556-1563

2016

  1. Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?

    Antioxidants and Redox Signaling, Vol. 25, Núm. 2, pp. 108-115

  2. Atherosclerosis, Mitochondrial Dysfunction and Oxidative Stress: Mitochondria-Targeted Anti-oxidants as Potential Therapy

    Frontiers in Medicinal Chemistry (Bentham Science Publishers), pp. 96-135

  3. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia

    Atherosclerosis, Vol. 247, pp. 40-47

  4. Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: Role of myeloperoxidase

    PLoS ONE, Vol. 11, Núm. 3

  5. Mitochondrial dysfunction and endoplasmic reticulum stress in diabetes

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2640-2649

  6. Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2650-2656

  7. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients

    Redox Biology, Vol. 10, pp. 200-205

2015

  1. Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance

    European Journal of Endocrinology, Vol. 173, Núm. 5, pp. 683-691

  2. Is Autophagy Altered in the Leukocytes of Type 2 Diabetic Patients?

    Antioxidants and Redox Signaling, Vol. 23, Núm. 13, pp. 1050-1056

  3. Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients

    Atherosclerosis, Vol. 242, Núm. 1, pp. 167-173